To determine if reduced SMG1 expression could be specific to PD and PDD, or might be more generalizable to other synucleinopathies, we assessed SMG1 expression in temporal cortex from 6 controls and 6 dementia with Lewy body (DLB) patients (see Table 3). This evidence concerns the gene SMG1 and Parkinson disease.